Neurizon Therapeutics (STU:ECQ0) Payments to Suppliers for Goods and Services : €-3.81 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Neurizon Therapeutics Payments to Suppliers for Goods and Services?

Neurizon Therapeutics's Payments to Suppliers for Goods and Services for the six months ended in Dec. 2023 was €-0.65 Mil.

Neurizon Therapeutics's Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Dec. 2023 was €-3.81 Mil.

Neurizon Therapeutics Payments to Suppliers for Goods and Services Historical Data

The historical data trend for Neurizon Therapeutics's Payments to Suppliers for Goods and Services can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Payments to Suppliers for Goods and Services Chart

Neurizon Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Payments to Suppliers for Goods and Services

Get a 7-Day Free Trial

-3.27

-2.94

-3.86

-3.31

-3.81

Neurizon Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Payments to Suppliers for Goods and Services	Get a 7-Day Free Trial															-2.15	-1.64	-1.71	-0.65	-3.16

Neurizon Therapeutics Payments to Suppliers for Goods and Services Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments to Suppliers for Goods and Services represents cash paid to suppliers when purchasing goods or services by the company in the direct cash flow method.

Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.81 Mil.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (STU:ECQ0) » Definitions » Payments to Suppliers for Goods and Services

Comparable Companies

Traded in Other Exchanges

PAA:Australia

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.pharmaust.com

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.

Neurizon Therapeutics Headlines

No Headlines